3.17
Precedente Chiudi:
$3.18
Aprire:
$3.29
Volume 24 ore:
3.02M
Relative Volume:
1.60
Capitalizzazione di mercato:
$514.92M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
79.25
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
-5.93%
1M Prestazione:
+105.84%
6M Prestazione:
+385.90%
1 anno Prestazione:
-9.94%
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Nome
Ironwood Pharmaceuticals Inc
Settore
Telefono
617-621-7722
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Confronta IRWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
IRWD
Ironwood Pharmaceuticals Inc
|
3.17 | 517.32M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Iniziato | Leerink Partners | Market Perform |
| 2024-08-08 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Iniziato | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Wells Fargo | Overweight |
| 2023-11-09 | Iniziato | Jefferies | Buy |
| 2023-09-28 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-02 | Iniziato | CapitalOne | Overweight |
| 2022-04-22 | Iniziato | Piper Sandler | Overweight |
| 2020-09-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Iniziato | Northland Capital | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Neutral |
| 2019-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Aggiornamento | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Iniziato | H.C. Wainwright | Sell |
| 2018-05-09 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Downgrade | Mizuho | Buy → Neutral |
| 2017-07-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Iniziato | Wells Fargo | Outperform |
| 2017-04-07 | Reiterato | Mizuho | Buy |
| 2017-02-22 | Reiterato | Barclays | Equal Weight |
| 2016-11-04 | Reiterato | Mizuho | Buy |
| 2016-10-24 | Reiterato | Wedbush | Neutral |
| 2016-10-10 | Reiterato | Mizuho | Buy |
| 2016-09-27 | Reiterato | WallachBeth | Hold |
Mostra tutto
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
How Ironwood Pharmaceuticals Inc. stock benefits from strong dollarJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
How Ironwood Pharmaceuticals Inc. (I76) stock trades under stagflationInsider Buying & Technical Entry and Exit Tips - newser.com
Is Ironwood Pharmaceuticals Inc. (I76) stock attractive for dividend growthJuly 2025 Review & Capital Protection Trading Alerts - newser.com
How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunityMarket Growth Report & Smart Allocation Stock Tips - newser.com
How Ironwood Pharmaceuticals Inc. (I76) stock moves on employment dataPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock deliver strong annual returnsWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform Dow Jones indexJuly 2025 Earnings & Safe Swing Trade Setups - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryMarket Activity Report & Real-Time Market Trend Scan - newser.com
Can Ironwood Pharmaceuticals Inc. stock continue upward trendDip Buying & Intraday High Probability Setup Alerts - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explainedQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Will Ironwood Pharmaceuticals Inc. outperform the marketWeekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock nowWeekly Profit Report & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-11-18 19:33:35 - newser.com
What’s next for Ironwood Pharmaceuticals Inc. stock priceTrade Volume Report & Fast Momentum Stock Entry Tips - newser.com
Will Ironwood Pharmaceuticals Inc. stock maintain dividend yieldPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Live market analysis of Ironwood Pharmaceuticals Inc.Earnings Risk Summary & Reliable Price Breakout Signals - newser.com
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leaderDollar Strength & Weekly Setup with ROI Potential - newser.com
Ironwood Pharmaceuticals (IRWD) Price Target Increased by 89.47% to 1.84 - Nasdaq
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):